Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3765156014 | Dibucaine 1 mg and prednisolone (as prednisolone sodium phosphate) 1.3 mg rectal suppository | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3765157017 | Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3765158010 | Cinchocaine 1 mg and prednisolone (as prednisolone sodium phosphate) 1.3 mg rectal suppository | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength denominator unit | Suppository | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength denominator unit | Suppository | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Has manufactured dose form | Conventional release rectal suppository | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Has unit of presentation | Suppository | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Is a | Product containing only cinchocaine and prednisolone in rectal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength numerator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Has basis of strength substance | Cinchocaine | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Has precise active ingredient | Prednisolone sodium phosphate | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Has precise active ingredient | Cinchocaine | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Has basis of strength substance | Prednisolone | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength numerator value | 1.3 | false | Inferred relationship | Existential restriction modifier | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets